Skip to main content
Quest Diagnostics

Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions

Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions

Authors: Crawford JM, Penberthy L, Pinto LA, Althoff KN, Assimon MM, Cohen O, Gillim L, Hammonds TL, Kapur S, Kaufman HW, Kwasny D, Liew JW, Meyer WA, Reynolds SL, Schleicher CB, Subbiah S, Theruviparampil C, Wallace ZS, Warner JL, Yoon S, Ziemba YC

Citation: Open Forum Infect Dis. 2025 Jan 23;12(1):ofaf021. doi: 10.1093/ofid/ofaf021.

Specialties: Infectious disease, Immunology, COVID-19

Related content

Publication
Anti-Nucleocapsid SARS-CoV-2 Antibody Seroprevalence in Previously Infected Persons With Immunocompromising Conditions-United States, 2020–2022
Publication
Self-Reported Longitudinal COVID-19 Vaccination Reactogenicity Profiles in Persons with Multiple Sclerosis
Publication
Assessing vulnerability to COVID 19 in high risk populations: the role of SARS CoV 2 spike targeted serology
Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.